Study to Assess the Effect of Intrauterine Adminstration of HCG Versus Endometrial Injury by Pipelle (NCT05050747) | Clinical Trial Compass
CompletedNot Applicable
Study to Assess the Effect of Intrauterine Adminstration of HCG Versus Endometrial Injury by Pipelle
Egypt402 participantsStarted 2021-09-27
Plain-language summary
Our study aims to describe the effect of the intrauterine adminstration of HCG versus the endometrial injury by pipelle on the ongoing pregnancy rate and the biochemical pregnancy rate in women with unexplained infertility undergoing ovulation induction. Also to describe the effect on the first trimester miscarriage rate, ectopic pregnancy rate, and multiple pregnancy.This study is an open-label, prospective, controlled study, multi-center study.
The study participants' relevant medical records will be collected and reviewed after obtaining informed consent for the participants. The study materials that will be used will include blood tests, and ultrasound. The study will involve three study arms.
Who can participate
Age range25 Years – 35 Years
SexFEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. Women with primary or secondary infertility due to unexplained infertility
✓. The age group of these women was 25-35 years
✓. BMI 18.5-29.9 kg/m2
✓. Normal hormone profile (FSH \<10 mIU/ml on day 2-3 and AMH more than 1)
✓. Euthyroid state or controlled thyroid state
✓. Bilateral free spill on HSG
Exclusion criteria
✕. Patients with severe male factor infertility; serum analysis count \< 10 million sperms /mL - sperm motility\<15% - 96%\<abnormal morphology)